Enzymatic synthesis of heparin

Sustainable Biotechnology: Sources of Renewable Energy

Volumn , Issue , 2010, Pages 259-277

  Liu, Renpeng ^a   Liu, Jian ^a  

^a University of North Carolina   (United States)

Author keywords

Anticoagulant; Enzymatic synthesis; Heparan sulfate; Heparin

Indexed keywords

EID: 84865604480     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-3295-9_14     Document Type: Chapter

References (60)

1. Howell, W. H., and Holt, E. (1918) Two new factors in blood coagulation-heparin and proantithrombin. Am J Physiol 47, 328-41.
2. Slaughter, T. F., and Greenberg, C. S. (1997) Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management. Anesthesiology 83, 667-75.
3. Kishimoto, T. K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J. C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., Al-Hakim, A., Bailey, G. S., Fraser, B., Roy, S., Rogers-Cotrone, T., Buhse, L., Whary, M., Fox, J., Nasr, M., Dal Pan, G. J., Shriver, Z., Langer, R. S., Venkataraman, G., Austen, K. F., Woodcock, J., and Sasisekharan, R. (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358, 2457-67.
4. Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J. C., Guglieri, S., Fraser, B., Al-Hakim, A., Gunay, N. S., Zhang, Z., Robinson, L., Buhse, L., Nasr, M., Woodcock, J., Langer, R., Venkataraman, G., Linhardt, R. J., Casu, B., Torri, G., and Sasisekharan, R. (2008) Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 26, 669-75.
5. Zhang, Z., Weïwer, M., Li, B., Kemp, M. M., Daman, T. H., and Linhardt, R. J. (2008) Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. J Med Chem 51, 5498-501.
6. Herbert, J. M., Hérault, J. P., Bernat, A., Savi, P., Schaeffer, P., Driguez, P. A., Duchaussoy, P., and Petitou, M. (2001) SR123781A, a synthetic heparin mimetic. Thromb Haemost 85, 852-60.
7. Petitou, M., and Van Boeckel, C. A. A. (2004) A synthetic antithrombin III binding pentasaccharide is now a drug! what comes next?. Angew Chem Int Ed 43, 3118-33.
8. Bauer, K. A., Hawkins, D. W., Peters, P. C., Petitou, M., Herbert, J. M., Van Boeckel, C. A. A., and Meuleman, D. G. (2002) Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents-the selective factor Xa inhibitors. Cardiovasc Drug Rev 20, 37-52.
9. Sinaÿ, P., Jacquinet, J. C., Petitou, M., Duchaussoy, P., Lederman, I., Choay, J., and Torri, G. (1984) Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III. Carbohydr Res 132, C5-9.
10. Petitou, M., Herault, L. P., Bernat, A., Driguez, P. A., Duchaussoy, P., Lormeau, J. C., and Herbert, J. M. (1999) Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 398, 417-22.
11. Fuster, M. M., and Esko, J. D. (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5, 526-42.
12. Parish, C. R. (2006) The role of heparan sulphate in inflammation. Nat Rev Immunol 6, 633-43.
13. Linhardt, R. J. (2003) 2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity. J Med Chem 46, 2551-64.
14. Bishop, J., Schuksz, M., and Esko, J. D. (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030-7.
15. Esko, J. D., and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J Clin Invest 108, 169-73.
16. Rosenberg, R. D., Showrak, N. W., Liu, J., Schwartz, J. J., and Zhang, L. (1997) Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?. J Clin Invest 99, 2062-70.
17. Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J., and Zako, M. (1999) Functions of cell surface heparan sulfate proteoglycans. Ann Rev Biochem 68, 729-77.
18. Liu, J., and Thorp, S. C. (2002) Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev 22, 1-25.
19. Liu, D., Shriver, Z., Venkataraman, G., Shabrawi, Y. E., and Sasisekharan, R. (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor groth and metastasis. Proc Natl Acad Sci 99, 568-73.
20. Liu, J., and Pedersen, L. C. (2007) Anticoagulant heparan sulfate: structural specificity and biosynthesis. Appl Microbiol Biotechnol 74, 263-72.
21. Kelly, T., Miao, H. Q., Yang, Y., Navarro, E., Kussie, P., Huang, Y., MacLeod, V., Casciano, J., Joseph, L., Zhan, F., Zangari, M., Barlogie, B., Shaughnessy, J., and Sanderson, R. D. (2003) High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 63, 8749-56.
22. Esko, J. D., and Selleck, S. B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71, 435-71.
23. Chapman, E., Best, M. D., Hanson, S. R., and Wong, C.-H. (2004) Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chemie Int Ed 42, 3526-48.
24. Gallagher, J. T. (2001) Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 108, 357-61.
25. Toida, T., Yoshida, H., Toyoda, H., Koshiishi, T., Imanari, T., Hileman, R. E., Fromm, J. R., and Linhardt, R. J. (1997) Structural differences and the presence of unsubstituted amino groups in heparan sulfates from different tissues and species. Biochem J 322, 499-506.
26. Liu, J., Shriver, Z., Pope, R. M., Thorp, S. C., Duncan, M. B., Copeland, R. J., Raska, C. S., Yoshida, K., Eisenberg, R. J., Cohen, G., Linhardt, R. J., and Sasisekharan, R. (2002) Characterization of a heparan sulfate octasaccharide that binds to herpes simplex viral type 1 glycoprotein D. J Biol Chem 277, 33456-67.
27. Powell, A. K., Fernig, D. G., and Turnbull, J. E. (2002) Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate: implications for dynamic assembly of a ternary signaling complex. J Biol Chem 277, 28554-63.
28. Mikhailov, D., Young, H. C., Linhardt, R. J., and Mayo, K. H. (1999) Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha: induction of a partially folded state and implications for heparin-induced thrombocytopenia. J Biol Chem 274, 25317-29.
29. Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., and Spear, P. G. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13-22.
30. Aikawa, J.-I., Grobe, K., Tsujimoto, M., and Esko, J. D. (2001) Multiple isozymes of heparan sulfates/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase: structure and activity of the fourth member, NDST4. J Biol Chem 276, 5876-82.
31. Fan, G., Xiao, L., Cheng, L., Wang, X., Sun, B., and Hu, G. (2000) Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett 467, 7-11.
32. Wang, L., Fuster, M., Sriramarao, P., and Esko, J. D. (2005) Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 6, 902-10.
33. Forsberg, E., Pejler, G., Ringvall, M., Lunderius, C., Tomasini-Johansson, B., Kusche-Gullberg, M., Eriksson, I., Ledin, J., Hellman, L., and Kjellen, L. (1999) Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400, 773-6.
34. Habuchi, H., Tanaka, M., Habuchi, O., Yoshida, K., Suzuki, H., Ban, K., and Kimata, K. (2000) The occurance of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J Biol Chem 275, 2859-68.
35. Martel, N., Lee, J., and Wells, P. S. (2005) Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106, 2710-5.
36. Kuberan, B., Lech, M. Z., Beeler, D. L., Wu, Z. L., and Rosenberg, R. D. (2003) Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nature Biotech 21, 1343-6.
37. Lindahl, U., Li, J., Kusche-Gullberg, M., Salmivirta, M., Alaranta, S., Veromaa, T., Emies, J., Roberts, I., Taylor, C., Oreste, P., Zoppetti, G., Naggi, A., Torri, G., and Casu, B. (2005) Generation of "neoheparin" from E. Coli K5 capsular polysaccharide. J Med Chem 48, 349-52.
38. Balagurunathan, K., Beeler, D. L., Lech, M., Wu, Z. L., and Rosenberg, R. D. (2003) Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides. J Biol Chem 278, 52613-21.
39. Kuberan, B., Beeler, D. L., Lawrence, R., Lech, M., and Rosenberg, R. D. (2003) Rapid twostep synthesis of mitrin from heparosan: a replacement for heparin. J Am Chem Soc 125, 12424-5.
40. Chen, J., Avci, F. Y., Muñoz, E. M., McDowell, L. M., Chen, M., Pedersen, L. C., Zhang, L., Linhardt, R. J., and Liu, J. (2005) Enzymatic redesigning of biological active heparan sulfate. J Biol Chem 280, 42817-25.
41. Chen, J., Jones, C. L., and Liu, J. (2007) Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. Chem Biol 14, 986-93.
42. Copeland, R. J., Balasubramaniam, A., Tiwari, V., Zhang, F., Bridges, A., Linhardt, R. J., Shukla, D., and Liu, J. (2008) Using a 3-O-sulfated heparan sulfate octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 47, 5774-83.
43. Edavettal, S. C., Lee, K. A., Negishi, M., Linhardt, R. J., Liu, J., and Pedersen, L. C. (2004) Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J Biol Chem 279, 25789-97.
44. Moon, A., Edavettal, S. C., Krahn, J. X., Munoz, E. M., Negishi, M., Linhardt, R. J., Liu, J., and Pedersen, L. C. (2004) Structural analysis of the sulfotransferase (3-OST-3) involved in the biosynthesis of an entry receptor of herpes simplex virus 1. J Biol Chem 279, 45185-93.
45. Xu, D., Moon, A., Song, D., Pedersen, L. C., and Liu, J. (2008) Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol 4, 200-2.
46. Duncan, M. B., Liu, M., Fox, C., and Liu, J. (2006) Characterization of the N-deacetylase domain from the heparan sulfate N-deacetylase/N- sulfotransferase 2. Biochem Biophys Res Commun 339, 1232-7.
47. Kakuta, Y., Sueyoshi, T., Negishi, M., and Pedersen, L. C. (1999) Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/N-sulfotransferase 1. J Biol Chem 274, 10673-6.
48. Hodson, N., Griffiths, G., Cook, N., Pourhossein, M., Gottfridson, E., Lind, T., Lidholt, K., and Roberts, I. S. (2000) Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharise, is an alpha-UDP-GlcNAc glycosyltransferase: the formation of a membrane-assocaited K5 biosynthetic complex requires KfiA, KfiB, and KfiC. J Biol Chem 275, 27311-5.
49. Chen, M., Bridges, A., and Liu, J. (2006) Determination of the substrate specificities of N-acetyl-D-glucosaminyl transferase. Biochemistry 45, 12358-65.
50. Deangelis, P. L., and White, C. L. (2002) Identification and molecular cloning of a heparosan synthase from pasteurella multocida types D. J Biol Chem 277, 6852-7.
51. Deangelis, P. L., and White, C. L. (2004) Identification of a distinct, cryptic heparosan synthase from pasteurella multocida types A, D, and F. J Bacteriol 186, 8529-32.
52. Muñoz, E., Xu, D., Avci, F., Kemp, M., Liu, J., and Linhardt, R. J. (2006) Enzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin-protein interactions. Biochem Biophys Res Commun 339, 597-602.
53. Xu, D., Tiwari, V., Xia, G., Clement, C., Shukla, D., and Liu, J. (2005) Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1. Biochem J 385, 451-9.
54. Burkart, M. D., Izumi, M., Chapman, E., Lin, C., and Wong, C.-H. (2000) Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides. J Org Chem 65, 5565-74.
55. Das, S. K., Mallet, J. M., Esnault, J., Driguez, P. A., Duchaussoy, P., Sizun, P., Herault, J. P., Herbert, J. M., Petitou, M., and Sinaÿ, P. (2001) Synthesis of conformationally locked L-iduronic acid derivatives: direct evidence for a critical role of the skew-boat 2S0 conformer in the activation of antithrombin by heparin. Chemistry 7, 4821-34.
56. Montgomery, R. I., Warner, M. S., Lum, B. J., and Spear, P. G. (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427-36.
57. Pertel, P. E., Fridberg, A., Parish, M. L., and Spear, P. G. (2001) Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology 279, 313-24.
58. Sismey-Ragatz, A. E., Dixy, E. G., Otto, N. J., Rejzek, M., Field, R. A., and Deangelis, P. L. (2007) Chemoenzymatic synthesis with distinct pasteurella heparosan synthases: monodisperse polymers and unnatural structures. J Biol Chem 282, 28321-7.
59. Weïwer, M., Sherwood, T., Green, D. E., Chen, M., De Angelis, P. L., Liu, J., and Linhardt, R. J. (2008) Synthesis of uridine 5'-diphosphoiduronic acid: a potential substrate for the chemoenzymatic synthesis of heparin. J Org Chem 73, 7631-7.
60. Linhardt, R. J., Dordick, J. S., Deangelis, P. L., and Liu, J. (2007) Enzymatic synthesis of glycosaminoglycan heparin. Semin Thromb Hemost 33, 453-65.